{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:35:32Z","timestamp":1792784132259,"version":"4.5.0"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T35HL110854"],"award-info":[{"award-number":["T35HL110854"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG078861\/AG078861-S1"],"award-info":[{"award-number":["AG078861\/AG078861-S1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG-064003"],"award-info":[{"award-number":["AG-064003"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54AG054345"],"award-info":[{"award-number":["U54AG054345"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG060621-05S1\/-05S2"],"award-info":[{"award-number":["AG060621-05S1\/-05S2"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Richard L Roudebush VA Medical Center","award":["I01BX005154"],"award-info":[{"award-number":["I01BX005154"]}],"id":[{"id":"https:\/\/ror.org\/01zpmbk67","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Richard L Roudebush VA Medical Center","award":["I01BX006399"],"award-info":[{"award-number":["I01BX006399"]}],"id":[{"id":"https:\/\/ror.org\/01zpmbk67","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>This comprehensive review delves into the intricate interplay between Alzheimer\u2019s disease (AD) and osteoporosis, two prevalent conditions with significant implications for individuals\u2019 quality of life. The purpose is to explore their bidirectional association, underpinned by common pathological processes such as aging, genetic factors, inflammation, and estrogen deficiency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Recent advances have shown promise in treating both Alzheimer\u2019s disease (AD) and osteoporosis by targeting disease-specific proteins and bone metabolism regulators. Monoclonal antibodies against beta-amyloid and tau for AD, as well as RANKL and sclerostin for osteoporosis, have displayed therapeutic potential. Additionally, ongoing research has identified neuroinflammatory genes shared between AD and osteoporosis, offering insight into the interconnected inflammatory mechanisms. This knowledge opens avenues for innovative dual-purpose therapies that could address both conditions, potentially revolutionizing treatment approaches for AD and osteoporosis simultaneously.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>This review underscores the potential for groundbreaking advancements in early diagnosis and treatment by unraveling the intricate connection between AD and bone health. It advocates for a holistic, patient-centered approach to medical care that considers both cognitive and bone health, ultimately aiming to enhance the overall well-being of individuals affected by these conditions.\u00a0This review article is part of a series of multiple manuscripts designed to determine the utility of using artificial intelligence for writing scientific reviews.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11914-023-00848-w","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T04:02:32Z","timestamp":1707451352000},"page":"152-164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["From the Mind to the Spine: The Intersecting World of Alzheimer\u2019s and Osteoporosis"],"prefix":"10.1007","volume":"22","author":[{"given":"Tyler J.","family":"Margetts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali J.","family":"Karnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian I.","family":"Plotkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Movila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian L.","family":"Oblak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill C.","family":"Fehrenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Kacena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,9]]},"reference":[{"key":"848_CR1","doi-asserted-by":"publisher","unstructured":"Kacena MA, Plotkin LI, Fehrenbacher JC. The use of artificial intelligence in writing scientific review articles. Curr Osteoporos Rep. https:\/\/doi.org\/10.1007\/s11914-023-00852-0.","DOI":"10.1007\/s11914-023-00852-0"},{"key":"848_CR2","doi-asserted-by":"publisher","unstructured":"Margetts TJ, Karnik SJ, Wang HS, et al. Use of AI language engine ChatGPT 4.0 to write a scientific review article examining the intersection of alzheimer\u2019s disease and bone. Curr Osteoporos Rep.\u00a02024. https:\/\/doi.org\/10.1007\/s11914-023-00853-z.","DOI":"10.1007\/s11914-023-00853-z"},{"issue":"9967","key":"848_CR3","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/S0140-6736(14)60569-9","volume":"385","author":"CD Mathers","year":"2015","unstructured":"Mathers CD, et al. Causes of international increases in older age life expectancy. Lancet. 2015;385(9967):540\u20138.","journal-title":"Lancet"},{"issue":"5","key":"848_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12802","volume":"17","author":"X Xia","year":"2018","unstructured":"Xia X, et al. Aging and Alzheimer\u2019s disease: comparison and associations from molecular to system level. Aging Cell. 2018;17(5): e12802.","journal-title":"Aging Cell"},{"key":"848_CR5","doi-asserted-by":"publisher","first-page":"5071438","DOI":"10.1155\/2016\/5071438","volume":"2016","author":"W Liang","year":"2016","unstructured":"Liang W, Chikritzhs T. The effect of age on fracture risk: a population-based cohort study. J Aging Res. 2016;2016:5071438.","journal-title":"J Aging Res"},{"issue":"3","key":"848_CR6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jocd.2007.05.004","volume":"10","author":"XG Cheng","year":"2007","unstructured":"Cheng XG, et al. Age-related bone mineral density, bone loss rate, prevalence of osteoporosis, and reference database of women at multiple centers in China. J Clin Densitom. 2007;10(3):276\u201384.","journal-title":"J Clin Densitom"},{"issue":"2","key":"848_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/2151458510389463","volume":"1","author":"SM Friedman","year":"2010","unstructured":"Friedman SM, et al. Dementia and hip fractures: development of a pathogenic framework for understanding and studying risk. Geriatr Orthop Surg Rehabil. 2010;1(2):52\u201362.","journal-title":"Geriatr Orthop Surg Rehabil"},{"issue":"26","key":"848_CR8","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1097\/MD.0000000000000188","volume":"93","author":"CH Tsai","year":"2014","unstructured":"Tsai CH, et al. Fracture as an independent risk factor of dementia: a nationwide population-based cohort study. Medicine (Baltimore). 2014;93(26):e188.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"848_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1034\/j.1601-5215.2002.51007.x","volume":"51","author":"LY Lui","year":"2003","unstructured":"Lui LY, et al. Bone loss predicts subsequent cognitive decline in older women: the study of osteoporotic fractures. J Am Geriatr Soc. 2003;51(1):38\u201343.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"848_CR10","first-page":"e12923","volume":"13","author":"K Dev","year":"2021","unstructured":"Dev K, et al. Prevalence of falls and fractures in Alzheimer\u2019s patients compared to general population. Cureus. 2021;13(1):e12923.","journal-title":"Cureus"},{"issue":"1","key":"848_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/ageing\/afq146","volume":"40","author":"NL Baker","year":"2011","unstructured":"Baker NL, et al. Hip fracture risk and subsequent mortality among Alzheimer\u2019s disease patients in the United Kingdom, 1988\u20132007. Age Ageing. 2011;40(1):49\u201354.","journal-title":"Age Ageing"},{"issue":"1","key":"848_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","volume":"4","author":"T Sozen","year":"2017","unstructured":"Sozen T, Ozisik L, Basaran NC. An overview and management of osteoporosis. Eur J Rheumatol. 2017;4(1):46\u201356.","journal-title":"Eur J Rheumatol"},{"key":"848_CR13","doi-asserted-by":"crossref","unstructured":"\u2022 Zhang, M, Hu S and Sun X. Alzheimer\u2019s disease and impaired bone microarchitecture, regeneration and potential genetic links. Life (Basel). 2023;13(2). This review identifies shared pathogenic mechanisms between Alzheimer\u2019s disease (AD) and osteoporosis and suggests that treatments targeting brain disorders could also benefit osteoporotic conditions, emphasizing the importance of preventing bone loss in AD patients.","DOI":"10.3390\/life13020373"},{"issue":"10","key":"848_CR14","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1002\/jbmr.1954","volume":"28","author":"WF Xia","year":"2013","unstructured":"Xia WF, et al. Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N-acetyl-L-cysteine. J Bone Miner Res. 2013;28(10):2122\u201335.","journal-title":"J Bone Miner Res."},{"issue":"5","key":"848_CR15","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/jbmr.299","volume":"26","author":"S Cui","year":"2011","unstructured":"Cui S, et al. APPswe\/Abeta regulation of osteoclast activation and RAGE expression in an age-dependent manner. J Bone Miner Res. 2011;26(5):1084\u201398.","journal-title":"J Bone Miner Res."},{"key":"848_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.neurobiolaging.2018.03.021","volume":"67","author":"CM Dengler-Crish","year":"2018","unstructured":"Dengler-Crish CM, et al. Evidence of Wnt\/beta-catenin alterations in brain and bone of a tauopathy mouse model of Alzheimer\u2019s disease. Neurobiol Aging. 2018;67:148\u201358.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"848_CR17","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3233\/JAD-160658","volume":"55","author":"CM Dengler-Crish","year":"2017","unstructured":"Dengler-Crish CM, Smith MA, Wilson GN. Early evidence of low bone density and decreased serotonergic synthesis in the Dorsal Raphe of a tauopathy model of Alzheimer\u2019s disease. J Alzheimers Dis. 2017;55(4):1605\u201319.","journal-title":"J Alzheimers Dis."},{"key":"848_CR18","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 JE, LL, et al.\u00a0Degradation of bone quality in a transgenic mouse model of Alzheimer\u2019s disease. J Bone Miner Res. 2022;37(12):2548-2565. This study showed that 5XFAD transgenic mice, a model for Alzheimer\u2019s disease, exhibited altered bone quality characterized by decreased mineralization, reduced crystallinity, accumulation of advanced glycation end products (AGEs), and compromised fracture toughness, suggesting a connection between amyloid-beta accumulation in the brain and changes in bone properties.","DOI":"10.1002\/jbmr.4723"},{"issue":"4","key":"848_CR19","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/alz.13016","volume":"19","author":"Alzheimer\u2019s disease facts and figures","year":"2023","unstructured":"Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2023;19(4):1598\u2013695.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"848_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.0959-9673.2005.00428.x","volume":"86","author":"M Tabaton","year":"2005","unstructured":"Tabaton M, Piccini A. Role of water-soluble amyloid-beta in the pathogenesis of Alzheimer\u2019s disease. Int J Exp Pathol. 2005;86(3):139\u201345.","journal-title":"Int J Exp Pathol."},{"issue":"2","key":"848_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/NRL.0b013e318187e76b","volume":"15","author":"J Williamson","year":"2009","unstructured":"Williamson J, Goldman J, Marder KS. Genetic aspects of Alzheimer disease. Neurologist. 2009;15(2):80\u20136.","journal-title":"Neurologist"},{"issue":"4","key":"848_CR22","first-page":"289","volume":"47","author":"RA Armstrong","year":"2009","unstructured":"Armstrong RA. The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer\u2019s disease. Folia Neuropathol. 2009;47(4):289\u201399.","journal-title":"Folia Neuropathol."},{"key":"848_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jsbmb.2016.03.012","volume":"160","author":"BC Riedel","year":"2016","unstructured":"Riedel BC, Thompson PM, Brinton RD. Age, APOE and sex: triad of risk of Alzheimer\u2019s disease. J Steroid Biochem Mol Biol. 2016;160:134\u201347.","journal-title":"J Steroid Biochem Mol Biol."},{"key":"848_CR24","doi-asserted-by":"crossref","unstructured":"Breijyeh Z and Karaman R. Comprehensive review on Alzheimer\u2019s disease: Causes and Treatment. Molecules. 2020;25(24).","DOI":"10.3390\/molecules25245789"},{"key":"848_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40035-018-0107-y","volume":"7","author":"X Du","year":"2018","unstructured":"Du X, Wang X, Geng M. Alzheimer\u2019s disease hypothesis and related therapies. Transl Neurodegener. 2018;7:2.","journal-title":"Transl Neurodegener"},{"issue":"17","key":"848_CR26","doi-asserted-by":"publisher","first-page":"7552","DOI":"10.1073\/pnas.88.17.7552","volume":"88","author":"P Cras","year":"1991","unstructured":"Cras P, et al. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc Natl Acad Sci U S A. 1991;88(17):7552\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"848_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/msj.20157","volume":"77","author":"DP Perl","year":"2010","unstructured":"Perl DP. Neuropathology of Alzheimer\u2019s disease. Mt Sinai J Med. 2010;77(1):32\u201342.","journal-title":"Mt Sinai J Med."},{"issue":"1","key":"848_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neulet.2004.05.017","volume":"366","author":"D Paris","year":"2004","unstructured":"Paris D, et al. Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci Lett. 2004;366(1):80\u20135.","journal-title":"Neurosci Lett."},{"issue":"9","key":"848_CR29","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","volume":"38","author":"GF Chen","year":"2017","unstructured":"Chen GF, et al. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin. 2017;38(9):1205\u201335.","journal-title":"Acta Pharmacol Sin."},{"issue":"1","key":"848_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/msj.20163","volume":"77","author":"MJ Metcalfe","year":"2010","unstructured":"Metcalfe MJ, Figueiredo-Pereira ME. Relationship between tau pathology and neuroinflammation in Alzheimer\u2019s disease. Mt Sinai J Med. 2010;77(1):50\u20138.","journal-title":"Mt Sinai J Med."},{"issue":"4","key":"848_CR31","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14(4):388\u2013405.","journal-title":"Lancet Neurol."},{"issue":"3","key":"848_CR32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s43587-021-00043-5","volume":"1","author":"WA Banks","year":"2021","unstructured":"Banks WA, et al. Healthy aging and the blood-brain barrier. Nat Aging. 2021;1(3):243\u201354.","journal-title":"Nat Aging."},{"issue":"6","key":"848_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/alzrt230","volume":"5","author":"WA Jefferies","year":"2013","unstructured":"Jefferies WA, et al. Adjusting the compass: new insights into the role of angiogenesis in Alzheimer\u2019s disease. Alzheimers Res Ther. 2013;5(6):64.","journal-title":"Alzheimers Res Ther."},{"issue":"9","key":"848_CR34","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1177\/0271678X20938146","volume":"40","author":"W Li","year":"2020","unstructured":"Li W, Lo EH. Leaky memories: Impact of APOE4 on blood-brain barrier and dementia. J Cereb Blood Flow Metab. 2020;40(9):1912\u20134.","journal-title":"J Cereb Blood Flow Metab."},{"issue":"7806","key":"848_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","volume":"581","author":"A Montagne","year":"2020","unstructured":"Montagne A, et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020;581(7806):71\u20136.","journal-title":"Nature"},{"issue":"17","key":"848_CR36","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1111\/j.1742-4658.2009.07174.x","volume":"276","author":"HS Lee","year":"2009","unstructured":"Lee HS, et al. Brain angiogenesis in developmental and pathological processes: regulation, molecular and cellular communication at the neurovascular interface. FEBS J. 2009;276(17):4622\u201335.","journal-title":"FEBS J"},{"issue":"1","key":"848_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1023\/B:AGEN.0000037335.17717.bf","volume":"7","author":"D Paris","year":"2004","unstructured":"Paris D, et al. Inhibition of angiogenesis by Abeta peptides. Angiogenesis. 2004;7(1):75\u201385.","journal-title":"Angiogenesis"},{"key":"848_CR38","doi-asserted-by":"crossref","unstructured":"Govindpani K, et al. Vascular dysfunction in Alzheimer\u2019s disease: a prelude to the pathological process or a consequence of it? J Clin Med. 2019;8(5).","DOI":"10.3390\/jcm8050651"},{"key":"848_CR39","first-page":"1","volume":"405","author":"N Sarafrazi","year":"2021","unstructured":"Sarafrazi N, Wambogo EA, Shepherd JA. Osteoporosis or low bone mass in older adults: United States, 2017\u20132018. NCHS Data Brief. 2021;405:1\u20138.","journal-title":"NCHS Data Brief"},{"issue":"1","key":"848_CR40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11657-023-01229-7","volume":"18","author":"A Singer","year":"2023","unstructured":"Singer A, et al. Treatment rates and healthcare costs of patients with fragility fracture by site of care: a real-world data analysis. Arch Osteoporos. 2023;18(1):42.","journal-title":"Arch Osteoporos."},{"issue":"4","key":"848_CR41","first-page":"IV3-8","volume":"48","author":"ML Brandi","year":"2009","unstructured":"Brandi ML. Microarchitecture, the key to bone quality. Rheumatology (Oxford). 2009;48(4):IV3-8.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"848_CR42","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1532-5415.1994.tb06859.x","volume":"42","author":"LJ Melton 3rd","year":"1994","unstructured":"Melton LJ 3rd, et al. Fracture risk in patients with Alzheimer\u2019s disease. J Am Geriatr Soc. 1994;42(6):614\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"848_CR43","doi-asserted-by":"publisher","first-page":"e59124","DOI":"10.1371\/journal.pone.0059124","volume":"8","author":"AM Tolppanen","year":"2013","unstructured":"Tolppanen AM, et al. Incident hip fractures among community dwelling persons with Alzheimer\u2019s disease in a Finnish nationwide register-based cohort. PLoS One. 2013;8(3):e59124.","journal-title":"PLoS One"},{"issue":"11","key":"848_CR44","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1002\/mds.25674","volume":"28","author":"M Amboni","year":"2013","unstructured":"Amboni M, Barone P, Hausdorff JM. Cognitive contributions to gait and falls: evidence and implications. Mov Disord. 2013;28(11):1520\u201333.","journal-title":"Mov Disord."},{"issue":"2","key":"848_CR45","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jns.2004.03.033","volume":"223","author":"Y Sato","year":"2004","unstructured":"Sato Y, et al. Risk factors for hip fracture among elderly patients with Alzheimer\u2019s disease. J Neurol Sci. 2004;223(2):107\u201312.","journal-title":"J Neurol Sci."},{"issue":"10","key":"848_CR46","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/j.1532-5415.1995.tb07005.x","volume":"43","author":"E Kipen","year":"1995","unstructured":"Kipen E, et al. Bone density, vitamin D nutrition, and parathyroid hormone levels in women with dementia. J Am Geriatr Soc. 1995;43(10):1088\u201391.","journal-title":"J Am Geriatr Soc."},{"issue":"2","key":"848_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/2151458512454878","volume":"3","author":"LJ Gleason","year":"2012","unstructured":"Gleason LJ, et al. Diagnosis and treatment of osteoporosis in high-risk patients prior to hip fracture. Geriatr Orthop Surg Rehabil. 2012;3(2):79\u201383.","journal-title":"Geriatr Orthop Surg Rehabil."},{"issue":"10","key":"848_CR48","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/j.1532-5415.1999.tb05196.x","volume":"47","author":"K Yaffe","year":"1999","unstructured":"Yaffe K, et al. Association between bone mineral density and cognitive decline in older women. J Am Geriatr Soc. 1999;47(10):1176\u201382.","journal-title":"J Am Geriatr Soc."},{"issue":"7","key":"848_CR49","doi-asserted-by":"publisher","first-page":"706","DOI":"10.2174\/1567205011666140812115818","volume":"11","author":"R Zhou","year":"2014","unstructured":"Zhou R, et al. Bone loss and osteoporosis are associated with conversion from mild cognitive impairment to Alzheimer\u2019s disease. Curr Alzheimer Res. 2014;11(7):706\u201313.","journal-title":"Curr Alzheimer Res."},{"issue":"1","key":"848_CR50","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1001\/archneur.62.1.107","volume":"62","author":"ZS Tan","year":"2005","unstructured":"Tan ZS, et al. Bone mineral density and the risk of Alzheimer disease. Arch Neurol. 2005;62(1):107\u201311.","journal-title":"Arch Neurol."},{"issue":"10","key":"848_CR51","doi-asserted-by":"publisher","first-page":"e19048","DOI":"10.1097\/MD.0000000000019048","volume":"99","author":"SY Kim","year":"2020","unstructured":"Kim SY, et al. Increased risk of dementia after distal radius, hip, and spine fractures. Medicine (Baltimore). 2020;99(10):e19048.","journal-title":"Medicine (Baltimore)"},{"key":"848_CR52","doi-asserted-by":"crossref","unstructured":"Vacas S, Cole DJ, and Cannesson M, Cognitive decline associated with anesthesia and surgery in older patients. JAMA, 2021.","DOI":"10.1001\/jama.2021.4773"},{"issue":"4","key":"848_CR53","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/gps.4832","volume":"33","author":"B Olofsson","year":"2018","unstructured":"Olofsson B, et al. Development of dementia in patients with femoral neck fracture who experience postoperative delirium-A three-year follow-up study. Int J Geriatr Psych. 2018;33(4):623\u201332.","journal-title":"Int J Geriatr Psych."},{"issue":"2","key":"848_CR54","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.bja.2022.01.005","volume":"129","author":"J Taylor","year":"2022","unstructured":"Taylor J, et al. Postoperative delirium and changes in the blood-brain barrier, neuroinflammation, and cerebrospinal fluid lactate: a prospective cohort study. Br J Anaesth. 2022;129(2):219\u201330.","journal-title":"Br J Anaesth."},{"issue":"5","key":"848_CR55","first-page":"1233","volume":"22","author":"MD Yu","year":"2018","unstructured":"Yu MD, Su BH, Zhang XX. Morphologic and molecular alteration during tibia fracture healing in rat. Eur Rev Med Pharmacol Sci. 2018;22(5):1233\u201340.","journal-title":"Eur Rev Med Pharmacol Sci."},{"issue":"2","key":"848_CR56","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/cbf.1199","volume":"23","author":"H Yeler","year":"2005","unstructured":"Yeler H, Tahtabas F, Candan F. Investigation of oxidative stress during fracture healing in the rats. Cell Biochem Funct. 2005;23(2):137\u20139.","journal-title":"Cell Biochem Funct."},{"issue":"5","key":"848_CR57","first-page":"376","volume":"7","author":"X Chen","year":"2012","unstructured":"Chen X, Guo C, Kong J. Oxidative stress in neurodegenerative diseases. Neural Regen Res. 2012;7(5):376\u201385.","journal-title":"Neural Regen Res."},{"issue":"1","key":"848_CR58","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4161\/cam.3.1.7402","volume":"3","author":"A Gella","year":"2009","unstructured":"Gella A, Durany N. Oxidative stress in Alzheimer disease. Cell Adh Migr. 2009;3(1):88\u201393.","journal-title":"Cell Adh Migr."},{"issue":"7","key":"848_CR59","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1111\/jgs.14238","volume":"64","author":"BE Neerland","year":"2016","unstructured":"Neerland BE, et al. Associations between delirium and preoperative cerebrospinal fluid c-reactive protein, interleukin-6, and interleukin-6 receptor in individuals with acute hip fracture. J Am Geriatr Soc. 2016;64(7):1456\u201363.","journal-title":"J Am Geriatr Soc."},{"issue":"11","key":"848_CR60","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.jalz.2018.02.014","volume":"14","author":"SKL Darweesh","year":"2018","unstructured":"Darweesh SKL, et al. Inflammatory markers and the risk of dementia and Alzheimer\u2019s disease: A meta-analysis. Alzheimers Dement. 2018;14(11):1450\u20139.","journal-title":"Alzheimers Dement."},{"issue":"5","key":"848_CR61","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.18632\/aging.101828","volume":"11","author":"CM Dengler-Crish","year":"2019","unstructured":"Dengler-Crish CM, Elefteriou F. Shared mechanisms: osteoporosis and Alzheimer\u2019s disease? Aging (Albany NY). 2019;11(5):1317\u20138.","journal-title":"Aging (Albany NY)"},{"issue":"12","key":"848_CR62","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1128\/MCB.01428-09","volume":"30","author":"I Kramer","year":"2010","unstructured":"Kramer I, et al. Osteocyte Wnt\/beta-catenin signaling is required for normal bone homeostasis. Mol Cell Biol. 2010;30(12):3071\u201385.","journal-title":"Mol Cell Biol."},{"issue":"52","key":"848_CR63","doi-asserted-by":"publisher","first-page":"20764","DOI":"10.1073\/pnas.0805133106","volume":"105","author":"L Pederson","year":"2008","unstructured":"Pederson L, et al. Regulation of bone formation by osteoclasts involves Wnt\/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci U S A. 2008;105(52):20764\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"848_CR64","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13041-019-0525-5","volume":"12","author":"L Jia","year":"2019","unstructured":"Jia L, Pina-Crespo J, Li Y. Restoring Wnt\/beta-catenin signaling is a promising therapeutic strategy for Alzheimer\u2019s disease. Mol Brain. 2019;12(1):104.","journal-title":"Mol Brain"},{"issue":"4","key":"848_CR65","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1096\/fj.09-139634","volume":"24","author":"F Fang","year":"2010","unstructured":"Fang F, et al. RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning\/memory in a mouse model of Alzheimer\u2019s disease. FASEB J. 2010;24(4):1043\u201355.","journal-title":"FASEB J"},{"issue":"7","key":"848_CR66","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nm890","volume":"9","author":"R Deane","year":"2003","unstructured":"Deane R, et al. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med. 2003;9(7):907\u201313.","journal-title":"Nat Med."},{"issue":"2","key":"848_CR67","doi-asserted-by":"publisher","first-page":"e23993","DOI":"10.4161\/tisb.23993","volume":"1","author":"SY Kook","year":"2013","unstructured":"Kook SY, et al. Disruption of blood-brain barrier in Alzheimer disease pathogenesis. Tissue Barriers. 2013;1(2):e23993.","journal-title":"Tissue Barriers"},{"issue":"4","key":"848_CR68","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1084\/jem.20051947","volume":"203","author":"Z Zhou","year":"2006","unstructured":"Zhou Z, et al. Regulation of osteoclast function and bone mass by RAGE. J Exp Med. 2006;203(4):1067\u201380.","journal-title":"J Exp Med"},{"issue":"7","key":"848_CR69","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.exger.2012.07.009","volume":"48","author":"KL Puig","year":"2013","unstructured":"Puig KL, Combs CK. Expression and function of APP and its metabolites outside the central nervous system. Exp Gerontol. 2013;48(7):608\u201311.","journal-title":"Exp Gerontol"},{"key":"848_CR70","doi-asserted-by":"crossref","unstructured":"Adair, T.H. and J.P. Montani, In: Angiogenesis. 2010: San Rafael (CA).","DOI":"10.4199\/C00017ED1V01Y201009ISP010"},{"key":"848_CR71","doi-asserted-by":"publisher","first-page":"115883","DOI":"10.1016\/j.bone.2021.115883","volume":"146","author":"FUR Bhatti","year":"2021","unstructured":"Bhatti FUR, et al. The effects of high fat diet, bone healing, and BMP-2 treatment on endothelial cell growth and function. Bone. 2021;146:115883.","journal-title":"Bone"},{"key":"848_CR72","doi-asserted-by":"crossref","unstructured":"Saran U, Gemini Piperni S, Chatterjee S. Role of angiogenesis in bone repair. Arch Biochem Biophys. 2014;561:109-17.","DOI":"10.1016\/j.abb.2014.07.006"},{"issue":"5","key":"848_CR73","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/jcb.10435","volume":"88","author":"LC Gerstenfeld","year":"2003","unstructured":"Gerstenfeld LC, et al. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem. 2003;88(5):873\u201384.","journal-title":"J Cell Biochem"},{"issue":"2","key":"848_CR74","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0925-4773(00)00532-3","volume":"100","author":"CI Colnot","year":"2001","unstructured":"Colnot CI, Helms JA. A molecular analysis of matrix remodeling and angiogenesis during long bone development. Mech Dev. 2001;100(2):245\u201350.","journal-title":"Mech Dev"},{"issue":"1","key":"848_CR75","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0169-328X(98)00190-9","volume":"62","author":"RN Kalaria","year":"1998","unstructured":"Kalaria RN, et al. Vascular endothelial growth factor in Alzheimer\u2019s disease and experimental cerebral ischemia. Brain Res Mol Brain Res. 1998;62(1):101\u20135.","journal-title":"Brain Res Mol Brain Res"},{"issue":"3","key":"848_CR76","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/s41380-019-0458-5","volume":"26","author":"ER Mahoney","year":"2021","unstructured":"Mahoney ER, et al. Brain expression of the vascular endothelial growth factor gene family in cognitive aging and Alzheimer\u2019s disease. Mol Psychiatry. 2021;26(3):888\u201396.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"848_CR77","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0197-4580(01)00285-8","volume":"23","author":"E Tarkowski","year":"2002","unstructured":"Tarkowski E, et al. Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer\u2019s disease and vascular dementia. Neurobiol Aging. 2002;23(2):237\u201343.","journal-title":"Neurobiol Aging"},{"key":"848_CR78","doi-asserted-by":"publisher","first-page":"263310552211092","DOI":"10.1177\/26331055221109254","volume":"17","author":"M Ali","year":"2022","unstructured":"Ali M, Bracko O. VEGF Paradoxically reduces cerebral blood flow in Alzheimer\u2019s disease mice. Neurosci Insights. 2022;17:26331055221109256.","journal-title":"Neurosci Insights"},{"issue":"Pt 4","key":"848_CR79","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1046\/j.1469-7580.1999.19440519.x","volume":"194","author":"A Horner","year":"1999","unstructured":"Horner A, et al. Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage. J Anat. 1999;194(Pt 4):519\u201324.","journal-title":"J Anat"},{"issue":"11","key":"848_CR80","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1182\/blood.V95.11.3289","volume":"95","author":"A Peled","year":"2000","unstructured":"Peled A, et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial\/stromal migration and engraftment of NOD\/SCID mice. Blood. 2000;95(11):3289\u201396.","journal-title":"Blood"},{"issue":"4","key":"848_CR81","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1046\/j.1365-2141.1999.01644.x","volume":"106","author":"K Imai","year":"1999","unstructured":"Imai K, et al. Selective secretion of chemoattractants for haemopoietic progenitor cells by bone marrow endothelial cells: a possible role in homing of haemopoietic progenitor cells to bone marrow. Br J Haematol. 1999;106(4):905\u201311.","journal-title":"Br J Haematol"},{"issue":"1","key":"848_CR82","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1182\/blood.V93.1.149","volume":"93","author":"K Imai","year":"1999","unstructured":"Imai K, et al. Selective transendothelial migration of hematopoietic progenitor cells: a role in homing of progenitor cells. Blood. 1999;93(1):149\u201356.","journal-title":"Blood"},{"key":"848_CR83","doi-asserted-by":"publisher","first-page":"1105620","DOI":"10.3389\/fnagi.2023.1105620","volume":"15","author":"L Castro-Aldrete","year":"2023","unstructured":"Castro-Aldrete L, et al. Sex and gender considerations in Alzheimer\u2019s disease: The Women\u2019s Brain Project contribution. Front Aging Neurosci. 2023;15:1105620.","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"848_CR84","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11910-010-0122-6","volume":"10","author":"SC Janicki","year":"2010","unstructured":"Janicki SC, Schupf N. Hormonal influences on cognition and risk for Alzheimer\u2019s disease. Curr Neurol Neurosci Rep. 2010;10(5):359\u201366.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"848_CR85","doi-asserted-by":"publisher","first-page":"16069","DOI":"10.1038\/nrdp.2016.69","volume":"2","author":"R Eastell","year":"2016","unstructured":"Eastell R, et al. Postmenopausal osteoporosis. Nat Rev Dis Primers. 2016;2:16069.","journal-title":"Nat Rev Dis Primers"},{"key":"848_CR86","doi-asserted-by":"crossref","unstructured":"Cheng CH, Chen LR, Chen KH. Osteoporosis due to hormone imbalance: an overview of the effects of estrogen deficiency and glucocorticoid overuse on bone turnover. Int J Mol Sci. 2022;23(3).","DOI":"10.3390\/ijms23031376"},{"issue":"3","key":"848_CR87","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1055\/s-0029-1216281","volume":"27","author":"VW Henderson","year":"2009","unstructured":"Henderson VW. Estrogens, episodic memory, and Alzheimer\u2019s disease: a critical update. Semin Reprod Med. 2009;27(3):283\u201393.","journal-title":"Semin Reprod Med."},{"issue":"1","key":"848_CR88","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1365-2265.2005.02297.x","volume":"63","author":"CE Lebrun","year":"2005","unstructured":"Lebrun CE, et al. Endogenous oestrogens are related to cognition in healthy elderly women. Clin Endocrinol (Oxf). 2005;63(1):50\u20135.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"848_CR89","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nrendo.2013.179","volume":"9","author":"SC Manolagas","year":"2013","unstructured":"Manolagas SC, O\u2019Brien CA, Almeida M. The role of estrogen and androgen receptors in bone health and disease. Nat Rev Endocrinol. 2013;9(12):699\u2013712.","journal-title":"Nat Rev Endocrinol."},{"key":"848_CR90","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3389\/fnagi.2019.00315","volume":"11","author":"A Rahman","year":"2019","unstructured":"Rahman A, et al. Sex and gender driven modifiers of Alzheimer\u2019s: the role for estrogenic control across age, race, medical, and lifestyle risks. Front Aging Neurosci. 2019;11:315.","journal-title":"Front Aging Neurosci."},{"issue":"9231","key":"848_CR91","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S0140-6736(00)02628-3","volume":"356","author":"K Yaffe","year":"2000","unstructured":"Yaffe K, et al. Cognitive decline in women in relation to non-protein-bound oestradiol concentrations. Lancet. 2000;356(9231):708\u201312.","journal-title":"Lancet"},{"issue":"2","key":"848_CR92","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0197-4580(03)00046-0","volume":"25","author":"EK Hoskin","year":"2004","unstructured":"Hoskin EK, et al. Elevated sex-hormone binding globulin in elderly women with Alzheimer\u2019s disease. Neurobiol Aging. 2004;25(2):141\u20137.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"848_CR93","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/ana.10677","volume":"54","author":"N Schupf","year":"2003","unstructured":"Schupf N, et al. Onset of dementia is associated with age at menopause in women with Down\u2019s syndrome. Ann Neurol. 2003;54(4):433\u20138.","journal-title":"Ann Neurol."},{"issue":"5","key":"848_CR94","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/ana.10521","volume":"53","author":"MI Geerlings","year":"2003","unstructured":"Geerlings MI, et al. Endogenous estradiol and risk of dementia in women and men: the Rotterdam Study. Ann Neurol. 2003;53(5):607\u201315.","journal-title":"Ann Neurol."},{"key":"848_CR95","doi-asserted-by":"crossref","unstructured":"Academic Committee of the Korean Society of M, et al. The 2020 menopausal hormone therapy guidelines. J Menopausal Med. 2020;26(2):69-98.","DOI":"10.6118\/jmm.20000"},{"key":"848_CR96","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1196\/annals.1347.005","volume":"1052","author":"RD Brinton","year":"2005","unstructured":"Brinton RD. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Ann N Y Acad Sci. 2005;1052:57\u201374.","journal-title":"Ann N Y Acad Sci."},{"key":"848_CR97","unstructured":"\u2022\u2022 J Xiong, et al. FSH blockade improves cognition in mice with Alzheimer\u2019s disease. Nature.  2022;603(7901):470-476.\u00a0Rising follicle-stimulating hormone (FSH) levels during menopause may exacerbate Alzheimer\u2019s disease pathology, but blocking FSH in mice reversed disease symptoms and cognitive decline, offering potential as a single treatment for Alzheimer\u2019s disease, obesity, osteoporosis, and dyslipidemia."},{"key":"848_CR98","doi-asserted-by":"publisher","first-page":"421746","DOI":"10.1155\/2015\/421746","volume":"2015","author":"R Florencio-Silva","year":"2015","unstructured":"Florencio-Silva R, et al. Biology of bone tissue: structure, function, and factors that influence bone cells. Biomed Res Int. 2015;2015:421746.","journal-title":"Biomed Res Int"},{"issue":"8","key":"848_CR99","doi-asserted-by":"publisher","first-page":"7317","DOI":"10.1074\/jbc.M412817200","volume":"280","author":"LI Plotkin","year":"2005","unstructured":"Plotkin LI, et al. Bisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular mechanisms downstream of extracellular signal-regulated kinase activation. J Biol Chem. 2005;280(8):7317\u201325.","journal-title":"J Biol Chem."},{"issue":"5","key":"848_CR100","first-page":"719","volume":"104","author":"S Kousteni","year":"2001","unstructured":"Kousteni S, et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell. 2001;104(5):719\u201330.","journal-title":"Cell"},{"issue":"5594","key":"848_CR101","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1126\/science.1074935","volume":"298","author":"S Kousteni","year":"2002","unstructured":"Kousteni S, et al. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science. 2002;298(5594):843\u20136.","journal-title":"Science"},{"issue":"9","key":"848_CR102","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1007\/s00198-013-2313-x","volume":"24","author":"Y Abu-Amer","year":"2013","unstructured":"Abu-Amer Y. NF-kappaB signaling and bone resorption. Osteoporos Int. 2013;24(9):2377\u201386.","journal-title":"Osteoporos Int"},{"issue":"4","key":"848_CR103","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jbspin.2012.03.007","volume":"79","author":"E Filaire","year":"2012","unstructured":"Filaire E, Toumi H. Reactive oxygen species and exercise on bone metabolism: friend or enemy? Joint Bone Spine. 2012;79(4):341\u20136.","journal-title":"Joint Bone Spine"},{"issue":"10","key":"848_CR104","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","volume":"68","author":"W Swardfager","year":"2010","unstructured":"Swardfager W, et al. A meta-analysis of cytokines in Alzheimer\u2019s disease. Biol Psych. 2010;68(10):930\u201341.","journal-title":"Biol Psych."},{"issue":"2","key":"848_CR105","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","volume":"21","author":"PL McGeer","year":"1995","unstructured":"McGeer PL, McGeer EG. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev. 1995;21(2):195\u2013218.","journal-title":"Brain Res Brain Res Rev."},{"key":"848_CR106","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1750-1326-6-55","volume":"6","author":"M Olabarria","year":"2011","unstructured":"Olabarria M, et al. Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer\u2019s disease mouse model: mechanism for deficient glutamatergic transmission? Mol Neurodegener. 2011;6:55.","journal-title":"Mol Neurodegener"},{"issue":"4","key":"848_CR107","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","volume":"78","author":"A Griciuc","year":"2013","unstructured":"Griciuc A, et al. Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron. 2013;78(4):631\u201343.","journal-title":"Neuron."},{"issue":"2","key":"848_CR108","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):117\u201327.","journal-title":"N Engl J Med."},{"issue":"7","key":"848_CR109","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/jbmr.4572","volume":"37","author":"AL Essex","year":"2022","unstructured":"Essex AL, et al. Triggering receptor expressed on myeloid cells 2 (TREM2) R47H variant causes distinct age- and sex-dependent musculoskeletal alterations in mice. J Bone Miner Res. 2022;37(7):1366\u201381.","journal-title":"J Bone Miner Res."},{"key":"848_CR110","doi-asserted-by":"crossref","unstructured":"Lee-Gosselin A, et al. TREM2-Deficient microglia attenuate tau spreading in vivo. Cells. 2023;12(12).","DOI":"10.3390\/cells12121597"},{"key":"848_CR111","doi-asserted-by":"crossref","unstructured":"Griciuc A, et al. TREM2 Acts downstream of CD33 in modulating microglial pathology in Alzheimer\u2019s disease. Neuron. 2019;103(5):820-835 e7.","DOI":"10.1016\/j.neuron.2019.06.010"},{"key":"848_CR112","doi-asserted-by":"publisher","first-page":"113506","DOI":"10.1016\/j.expneurol.2020.113506","volume":"336","author":"JB Ruganzu","year":"2021","unstructured":"Ruganzu JB, et al. TREM2 overexpression rescues cognitive deficits in APP\/PS1 transgenic mice by reducing neuroinflammation via the JAK\/STAT\/SOCS signaling pathway. Exp Neurol. 2021;336:113506.","journal-title":"Exp Neurol."},{"issue":"15","key":"848_CR113","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.2106\/JBJS.20.00989","volume":"103","author":"JS Kimball","year":"2021","unstructured":"Kimball JS, Johnson JP, Carlson DA. Oxidative stress and osteoporosis. J Bone Joint Surg Am. 2021;103(15):1451\u201361.","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"848_CR114","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bbrc.2003.12.073","volume":"314","author":"XC Bai","year":"2004","unstructured":"Bai XC, et al. Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Biochem Biophys Res Commun. 2004;314(1):197\u2013207.","journal-title":"Biochem Biophys Res Commun."},{"issue":"2","key":"848_CR115","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.bone.2012.11.038","volume":"54","author":"RL Jilka","year":"2013","unstructured":"Jilka RL, Noble B, Weinstein RS. Osteocyte apoptosis. Bone. 2013;54(2):264\u201371.","journal-title":"Bone"},{"issue":"2","key":"848_CR116","doi-asserted-by":"publisher","first-page":"209","DOI":"10.11138\/ccmbm\/2017.14.1.209","volume":"14","author":"V Domazetovic","year":"2017","unstructured":"Domazetovic V, et al. Oxidative stress in bone remodeling: role of antioxidants. Clin Cases Miner Bone Metab. 2017;14(2):209\u201316.","journal-title":"Clin Cases Miner Bone Metab."},{"key":"848_CR117","doi-asserted-by":"publisher","first-page":"102294","DOI":"10.1016\/j.ctim.2019.102294","volume":"49","author":"L Cassidy","year":"2020","unstructured":"Cassidy L, et al. Oxidative stress in Alzheimer\u2019s disease: a review on emergent natural polyphenolic therapeutics. Complement Ther Med. 2020;49:102294.","journal-title":"Complement Ther Med."},{"issue":"3","key":"848_CR118","first-page":"160","volume":"3","author":"A Behrouzi","year":"2022","unstructured":"Behrouzi A, Kelley MR, Fehrenbacher JC. Oxidative DNA Damage: A Role in Altering neuronal function. J Cell Signal. 2022;3(3):160\u20136.","journal-title":"J Cell Signal"},{"issue":"1","key":"848_CR119","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1046\/j.1471-4159.1997.69010273.x","volume":"69","author":"JN Keller","year":"1997","unstructured":"Keller JN, et al. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J Neurochem. 1997;69(1):273\u201384.","journal-title":"J Neurochem."},{"issue":"1","key":"848_CR120","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1046\/j.1471-4159.1997.68010255.x","volume":"68","author":"RJ Mark","year":"1997","unstructured":"Mark RJ, et al. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J Neurochem. 1997;68(1):255\u201364.","journal-title":"J Neurochem"},{"issue":"2","key":"848_CR121","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S0014-4886(02)00059-6","volume":"180","author":"E Tamagno","year":"2003","unstructured":"Tamagno E, et al. H2O2 and 4-hydroxynonenal mediate amyloid beta-induced neuronal apoptosis by activating JNKs and p38MAPK. Exp Neurol. 2003;180(2):144\u201355.","journal-title":"Exp Neurol."},{"issue":"1","key":"848_CR122","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00223-013-9774-y","volume":"94","author":"T Bellido","year":"2014","unstructured":"Bellido T. Osteocyte-driven bone remodeling. Calcif Tissue Int. 2014;94(1):25\u201334.","journal-title":"Calcif Tissue Int."},{"issue":"2","key":"848_CR123","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/jbmr.320","volume":"26","author":"LF Bonewald","year":"2011","unstructured":"Bonewald LF. The amazing osteocyte. J Bone Miner Res. 2011;26(2):229\u201338.","journal-title":"J Bone Miner Res."},{"issue":"4","key":"848_CR124","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00223-015-9961-0","volume":"96","author":"F Fontani","year":"2015","unstructured":"Fontani F, et al. Glutathione, N-acetylcysteine and lipoic acid down-regulate starvation-induced apoptosis, RANKL\/OPG ratio and sclerostin in osteocytes: involvement of JNK and ERK1\/2 signalling. Calcif Tissue Int. 2015;96(4):335\u201346.","journal-title":"Calcif Tissue Int."},{"issue":"1","key":"848_CR125","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13195-017-0297-z","volume":"9","author":"M Crous-Bou","year":"2017","unstructured":"Crous-Bou M, et al. Alzheimer\u2019s disease prevention: from risk factors to early intervention. Alzheimers Res Ther. 2017;9(1):71.","journal-title":"Alzheimers Res Ther."},{"key":"848_CR126","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.trci.2019.03.004","volume":"5","author":"J Eldufani","year":"2019","unstructured":"Eldufani J, Blaise G. The role of acetylcholinesterase inhibitors such as neostigmine and rivastigmine on chronic pain and cognitive function in aging: a review of recent clinical applications. Alzheimers Dement (N Y). 2019;5:175\u201383.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"2","key":"848_CR127","first-page":"1479","volume":"20","author":"K Sharma","year":"2019","unstructured":"Sharma K. Cholinesterase inhibitors as Alzheimer\u2019s therapeutics (Review). Mol Med Rep. 2019;20(2):1479\u201387.","journal-title":"Mol Med Rep"},{"key":"848_CR128","unstructured":"Singh R, Sadiq NM. Cholinesterase inhibitors, in StatPearls. 2023: Treasure Island (FL)."},{"key":"848_CR129","unstructured":"Kuns B, Rosani A, Varghese D, Memantine, in StatPearls. 2023: Treasure Island (FL)."},{"issue":"4","key":"848_CR130","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-160763","volume":"57","author":"R Wang","year":"2017","unstructured":"Wang R, Reddy PH. Role of glutamate and NMDA receptors in Alzheimer\u2019s disease. J Alzheimers Dis. 2017;57(4):1041\u20138.","journal-title":"J Alzheimers Dis."},{"key":"848_CR131","first-page":"9343514","volume":"2022","author":"SA Beshir","year":"2022","unstructured":"Beshir SA, et al. Aducanumab therapy to treat Alzheimer\u2019s disease: a narrative review. Int J Alzheimers Dis. 2022;2022:9343514.","journal-title":"Int J Alzheimers Dis."},{"key":"848_CR132","unstructured":"\u2022 CH Dyck van et al. Lecanemab in early Alzheimer\u2019s disease N Engl J Med. 2023;388(1):9-21. Lecanemab, an antibody targeting amyloid-beta, showed a reduction in amyloid markers and moderately slowed cognitive and functional decline in early Alzheimer\u2019s disease patients over 18 months compared to placebo, though it was linked to certain adverse events, warranting longer trials to determine its overall efficacy and safety."},{"key":"848_CR133","doi-asserted-by":"crossref","unstructured":"Tonk CH, et al. Therapeutic treatments for osteoporosis-which combination of pills is the best among the bad? Int J Mol Sci. 2022;23(3).","DOI":"10.3390\/ijms23031393"},{"key":"848_CR134","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/fmed.2017.00234","volume":"4","author":"H Bi","year":"2017","unstructured":"Bi H, et al. Key triggers of osteoclast-related diseases and available strategies for targeted therapies: a review. Front Med (Lausanne). 2017;4:234.","journal-title":"Front Med (Lausanne)"},{"key":"848_CR135","doi-asserted-by":"crossref","unstructured":"Russow G, et al. Anabolic therapies in osteoporosis and bone regeneration. Int J Mol Sci. 2018;20(1).","DOI":"10.3390\/ijms20010083"},{"issue":"3","key":"848_CR136","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00223-018-0422-4","volume":"103","author":"A Makino","year":"2018","unstructured":"Makino A, et al. Abaloparatide exerts bone anabolic effects with less stimulation of bone resorption-related factors: a comparison with teriparatide. Calcif Tissue Int. 2018;103(3):289\u201397.","journal-title":"Calcif Tissue Int."},{"issue":"5","key":"848_CR137","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1056\/NEJMoa1305224","volume":"370","author":"MR McClung","year":"2014","unstructured":"McClung MR, et al. Romosozumab in postmenopausal women with low bone mineral density. N Engl J Med. 2014;370(5):412\u201320.","journal-title":"N Engl J Med."},{"issue":"16","key":"848_CR138","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman F, et al. Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med. 2016;375(16):1532\u201343.","journal-title":"N Engl J Med."},{"issue":"1","key":"848_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00223-004-0258-y","volume":"77","author":"P Vestergaard","year":"2005","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L. Reduced relative risk of fractures among users of lithium. Calcif Tissue Int. 2005;77(1):1\u20138.","journal-title":"Calcif Tissue Int."},{"issue":"48","key":"848_CR140","doi-asserted-by":"publisher","first-page":"17406","DOI":"10.1073\/pnas.0505259102","volume":"102","author":"P Clement-Lacroix","year":"2005","unstructured":"Clement-Lacroix P, et al. Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice. Proc Natl Acad Sci U S A. 2005;102(48):17406\u201311.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"848_CR141","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3233\/JAD-2011-101875","volume":"24","author":"X Zhang","year":"2011","unstructured":"Zhang X, et al. Long-term treatment with lithium alleviates memory deficits and reduces amyloid-beta production in an aged Alzheimer\u2019s disease transgenic mouse model. J Alzheimers Dis. 2011;24(4):739\u201349.","journal-title":"J Alzheimers Dis."},{"issue":"5","key":"848_CR142","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1192\/bjp.bp.110.080044","volume":"198","author":"OV Forlenza","year":"2011","unstructured":"Forlenza OV, et al. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. Br J Psych. 2011;198(5):351\u20136.","journal-title":"Br J Psych."},{"key":"848_CR143","doi-asserted-by":"crossref","unstructured":"Toledo EM, Inestrosa NC, Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe\/PSEN1DeltaE9 mouse model of Alzheimer\u2019s disease. Mol Psychiatry. 2010;15(3):272-85, 228.","DOI":"10.1038\/mp.2009.72"},{"key":"848_CR144","unstructured":"\u2022 Gera S, et al. FSH-blocking therapeutic for osteoporosis. Elife. 2022;11. A newly developed humanized antibody, MS-Hu6, effectively prevents and treats osteoporosis in mice, exhibits favorable safety profiles in monkeys, and demonstrates promise for future human trials given its stability, non-immunogenicity, and biodistribution properties targeting bone and bone marrow."}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-023-00848-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11914-023-00848-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-023-00848-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T15:31:03Z","timestamp":1709825463000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11914-023-00848-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":144,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["848"],"URL":"https:\/\/doi.org\/10.1007\/s11914-023-00848-w","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"20 December 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Kacena is an Editor-in-Chief for Current Osteoporosis Reports. Drs. Plotkin and Fehrenbacher are Section Editors for Current Osteoporosis Reports.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}